Editorial scope: This guide addresses analytical evidence, documentation, and research-procurement literacy. Conclusions are limited to the records and methods discussed.

Mass spectrometry reports mass-to-charge

A mass spectrometer creates ions, separates them according to mass-to-charge ratio, and detects them. The horizontal axis commonly shows m/z and the vertical axis shows relative signal intensity.

Because the instrument measures ions, the displayed m/z value may not equal the neutral molecular mass printed for the peptide.

Peptides often appear in several charge states

A peptide carrying multiple charges produces a family of peaks at different m/z values. Deconvolution software can combine that pattern into an estimated neutral or average mass.

A useful report makes clear whether it shows raw ions, a deconvoluted spectrum, or both.

Expected and observed mass must use the same definition

Compare like with like: monoisotopic mass with monoisotopic mass, or average mass with average mass. Terminal modifications, disulfide bonds, isotopic labels, conjugates, salt assumptions, and sequence changes affect the expected value.

A small unexplained difference deserves clarification rather than automatic rounding.

Adducts, fragments, and isotope patterns add complexity

Sodium or other adducts can shift observed ions, while in-source fragmentation can create additional signals. Isotope patterns and instrument resolution influence how closely neighboring species can be distinguished.

A cropped peak label without interpretation provides less support than a report linking the observed ion series to the expected analyte.

  • Expected molecular mass and chemical form
  • Observed ion or deconvoluted mass
  • Mass error and units
  • Ionization and instrument context
  • Sample and report identifiers

A matching mass supports identity, not every attribute

Agreement between expected and observed mass supports the presence of the represented molecule. It does not automatically establish sequence order, total purity, quantity, or absence of isobaric or closely related material.

Chromatographic separation, peptide mapping, tandem MS, or other procedures may provide complementary specificity when needed.

Review the report as part of one evidence chain

Confirm that the MS sample matches the HPLC sample and current lot. Record the instrument output, interpretation, laboratory, date, and any unexplained signals.

The strongest conclusion states precisely which identity proposition the result supports and which questions remain open.

Sources and further reading

Primary and standards-based sources used to frame this educational overview:

Peptide Due Diligence Research Brief

Keep the evidence in view.

Receive concise briefings on analytical testing, documentation quality, supplier transparency, and new additions to the research library.

By subscribing, you agree to receive PDD research emails. Unsubscribe at any time.

Already subscribed? Get your free checklist.

Continue your due diligence